Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ragnar E Löfstedt

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Risk Analysis : an Official Publication of the Society for Risk Analysis|May 10, 2013
The informal European Parliamentary Working Group on Risk--history, remit, and future plans: a personal viewRagnar E Löfstedt
Risk Analysis : an Official Publication of the Society for Risk Analysis|May 7, 2003
Swedish chemical regulation: an overview and analysisRagnar E Löfstedt
Therapeutic Innovation & Regulatory Science|September 21, 2018
Transparency at the EMA: More Evidence Is NeededRagnar E Löfstedt
Risk Analysis : an Official Publication of the Society for Risk Analysis|November 3, 2010
Nanotechnology risk communication past and prologueAnn Bostrom, Ragnar E Löfstedt
Drug Safety|July 25, 2020
Pharmaceutical Benefit-Risk Perception and Age Differences in the USA and GermanyDominic H P Balog-Way, Darrick Evensen, Ragnar E Löfstedt
Risk Analysis : an Official Publication of the Society for Risk Analysis|September 18, 2010
Nano risk analysis: advancing the science for nanomaterials risk managementJo Anne Shatkin, Linda Carolyn Abbott, Ann E Bradley, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Risk Analysis : an Official Publication of the Society for Risk Analysis|May 10, 2013
The informal European Parliamentary Working Group on Risk--history, remit, and future plans: a personal viewRagnar E Löfstedt
Risk Analysis : an Official Publication of the Society for Risk Analysis|May 7, 2003
Swedish chemical regulation: an overview and analysisRagnar E Löfstedt
Therapeutic Innovation & Regulatory Science|September 21, 2018
Transparency at the EMA: More Evidence Is NeededRagnar E Löfstedt
Risk Analysis : an Official Publication of the Society for Risk Analysis|November 3, 2010
Nanotechnology risk communication past and prologueAnn Bostrom, Ragnar E Löfstedt
Drug Safety|July 25, 2020
Pharmaceutical Benefit-Risk Perception and Age Differences in the USA and GermanyDominic H P Balog-Way, Darrick Evensen, Ragnar E Löfstedt
Risk Analysis : an Official Publication of the Society for Risk Analysis|September 18, 2010
Nano risk analysis: advancing the science for nanomaterials risk managementJo Anne Shatkin, Linda Carolyn Abbott, Ann E Bradley, et al.
Pageof 1